Twist Bioscience (TWST) Current Leases (2019 - 2026)

Twist Bioscience (TWST) has reported Current Leases for 8 consecutive years, with $10.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Leases fell 31.38% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $10.4 million (down 31.38% YoY), while the FY2025 annual figure was $13.8 million, down 6.64% from the prior year.
• Current Leases slipped to $10.4 million in Q1 2026 per TWST's latest filing, from $12.2 million in the prior quarter.
• Across five years, Current Leases topped out at $15.5 million in Q2 2025 and bottomed at $10.4 million in Q1 2026.
• Historically, Current Leases has averaged $14.1 million across 5 years, with a median of $14.4 million in 2022.
• Annual changes were most pronounced in 2022 — Current Leases jumped 117.47% — and 2026, when it plunged 31.38%.
• Twist Bioscience's Current Leases stood at $14.2 million in 2022, then increased by 4.08% to $14.8 million in 2023, then climbed by 1.5% to $15.0 million in 2024, then dropped by 18.55% to $12.2 million in 2025, then declined by 14.7% to $10.4 million in 2026.
• Business Quant data shows TWST's Current Leases at $10.4 million in Q1 2026, $12.2 million in Q4 2025, and $13.8 million in Q3 2025.